ORYZON Awarded EU Seal of Excellence and Public Financing of $2M USD to Develop Iadademstat in Acute Myeloid Leukemia
Non-refundable funds from the Next Generation-EU program MADRID, Spain and CAMBRIDGE, Mass., June 07, 2022…
News
scPharmaceuticals Inc. Announces Abstracts Accepted for Presentation at the American Association of Heart Failure Nurses 18th Annual Meeting
Oral and moderated poster presentations of FREEDOM-HF study to be presented BURLINGTON, Mass., June 07,…
Enlivex to Present at the 2022 Jefferies Healthcare Conference
Nes-Ziona, Israel, June 07, 2022 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage…
Soleno Therapeutics Announces Presentations at ENDO 2022
REDWOOD CITY, Calif., June 07, 2022 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO),…
Jasper Therapeutics to Participate in the William Blair 42nd Annual Growth Stock Conference
REDWOOD CITY, Calif., June 07, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a…
eFFECTOR Therapeutics to Present at JMP Securities Life Sciences Conference
SAN DIEGO and REDWOOD CITY, Calif., June 07, 2022 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics, Inc….
Ashvattha Therapeutics Announces Poster Presentation of Preclinical Data on Hydroxyl Dendrimer-Based Therapeutics at the 2022 Neurofibromatosis (NF) Conference
Scientific collaborators at Indiana University School of Medicine will present preclinical data demonstrating Ashvattha’s hydroxyl…
Aquestive Therapeutics to Participate in JMP Securities Life Sciences Conference
WARREN, N.J., June 07, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical…
Ascendis Pharma A/S Announces Two Oral Presentations Highlighting the Potential for TransCon™ PTH to be a Replacement Therapy for Adult Hypoparathyroidism at ENDO 2022
– Late-breaker oral presentation of TransCon PTH Phase 3 PaTHway Trial data in adult hypoparathyroidism…
Science 37® to Participate in Upcoming Investor Conferences
RESEARCH TRIANGLE PARK, N.C., June 07, 2022 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq:…
Novozymes extends the lifetime of textiles with sustainable innovation
AdobeStock_436255963 Biopolishing for MMCF is not just a quality win in terms of pilling performance….
Mindset Pharma to Participate in Upcoming Conferences in June 2022
TORONTO, June 07, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
Tilray Medical Launches Sleep-Oriented CBN Night Oil for Medical Cannabis Patients in Canada
Aphria Medical CBN Oil New Aphria CBN Night Oil formulated for night-time use LEAMINGTON, Ontario,…
Acerus Announces Amendment and Restatement of the Promissory Note Related to the Up-Front Fee Payable to Former Serenity Securityholders
TORONTO, June 07, 2022 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP;…
Medicenna to Announce Fiscal Year 2022 Financial Results and Operational Highlights on Wednesday, June 22, 2022
TORONTO and HOUSTON, June 07, 2022 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the…
Crinetics Pharmaceuticals to Participate in the JMP Securities Life Sciences Conference
SAN DIEGO, June 07, 2022 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals (Nasdaq: CRNX), a clinical-stage pharmaceutical…
Inozyme Pharma Appoints Kurt Gunter, M.D., as Chief Medical Officer
BOSTON, June 07, 2022 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare…
Novo Nordisk A/S:
Novo Nordisk – major shareholder announcement Bagsværd, Denmark, 7 June 2022 – Novo Nordisk today…
MetasTx LLC Raises Funds, Engages Manufacturing Partner, And Advances Phase One Development
BASKING RIDGE, N.J., June 07, 2022 (GLOBE NEWSWIRE) — MetasTx LLC is driven to create…
Skye Bioscience Expands Cannabinoid Pharmaceutical Innovation Program with Leading Cannabinoid Medicinal Chemistry Groups
New collaborations focused on building library of novel cannabinoid derivatives and small molecules capable of…